Galindo Alejandro's Form 4 filing
Mannkind Corp (MNKD) · filed Aug 23, 2022
- Accession no.
- 0001209191-22-047280
- Filed
- Aug 23, 2022
- Trade date
- Aug 22, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $17.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Galindo AlejandroCIK 0001821447 | Officer (EVP Endocrine Business Unit) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 | Common Stock, $0.01 Par Value | SSaleDisposed | −4,600 | $3.85 | −$17,710 | 777,090 | Direct | |
| Aug 22, 2022 | Common Stock, $0.01 Par Value | SSaleDisposed | −15 | $3.84 | −$57.6 | 777,075 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.